Frequently Asked Questions
Read this information carefully before you start taking AMITIZA. Each time you get more AMITIZA, read the accompanying information. There may be important new information on safety or other factors. This information does not take the place of talking to your healthcare provider about your medical condition or treatment. Only your healthcare provider can determine if treatment with AMITIZA may be right for you.
Q: What is AMITIZA?
Q: What is Chronic Idiopathic Constipation (CIC)?
Q: What should I tell my healthcare provider before starting AMITIZA?
Q: Who should not take AMITIZA?
Q: What other important information should I know about AMITIZA?
Q: What are the possible side effects of AMITIZA (24 mcg) twice daily for Chronic Idiopathic Constipation?
Q: How should I take AMITIZA?
Q: What should I do if I miss a dose?
Q: How soon will AMITIZA begin to work for CIC?
Q: Will AMITIZA interfere with other medications?
Q: How do I store AMITIZA?
General information about AMITIZA
Q: Where can I find more information about AMITIZA?
Q: What are the ingredients in AMITIZA?
Q: I've already paid for my prescription of AMITIZA. Is there a mail-in rebate available?
Important Safety Information
AMITIZA (lubiprostone) is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider (HCP) should evaluate your condition before starting AMITIZA. You should not take AMITIZA if you have severe diarrhea.
Some patients taking AMITIZA may experience nausea or diarrhea. If nausea occurs, take AMITIZA with food and water, if it becomes severe, tell your HCP. If your diarrhea becomes severe, stop taking AMITIZA and tell your HCP.
Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your HCP if you experience these symptoms.
The most common side effects of taking AMITIZA (24 mcg) twice daily are nausea, diarrhea, headache, abdominal pain, abdominal distension, and gas for patients treated for CIC; nausea and diarrhea for patients treated for
Tell your HCP if you are taking a diphenylheptane opioid (e.g., methadone).
AMITIZA has not been studied in pregnant women. Based on animal studies, AMITIZA may cause fetal harm. AMITIZA should only be used during pregnancy if the potential benefits justify the potential risk to the fetus. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your HCP to evaluate the risks to the fetus. Tell your HCP if you are nursing and monitor infants for diarrhea.
Tell your HCP if you have liver problems.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. "Idiopathic" means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids, a type of prescription pain medicine, in adults with chronic, non-cancer pain. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years of age and older.